Culprit Vessel Percutaneous Coronary Intervention Versus Multivessel and Staged Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease

被引:255
|
作者
Hannan, Edward L. [1 ]
Samadashvili, Zaza
Walford, Gary [2 ]
Holmes, David R., Jr. [3 ]
Jacobs, Alice K. [4 ]
Stamato, Nicholas J. [6 ]
Venditti, Ferdinand J. [5 ]
Sharma, Samin [7 ]
King, Spencer B., III [8 ]
机构
[1] SUNY Albany, Sch Publ Hlth, Rensselaer, NY 12144 USA
[2] St Josephs Hosp, Syracuse, NY USA
[3] Mayo Clin, Rochester, MN USA
[4] Boston Univ, Med Ctr, Boston, MA USA
[5] Albany Med Ctr, Albany, NY USA
[6] United Hlth Serv, Binghamton, NY USA
[7] Mt Sinai Med Ctr, New York, NY 10029 USA
[8] St Josephs Hlth Syst, Atlanta, GA USA
关键词
DRUG-ELUTING STENTS; BARE-METAL STENTS; REVASCULARIZATION; METAANALYSIS; OUTCOMES; SAFETY; SINGLE;
D O I
10.1016/j.jcin.2009.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The purpose of this study was to examine the differences in in-hospital and longer-term mortality for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease as a function of whether they underwent single-vessel (culprit vessel) percutaneous coronary interventions (PCIs) or multivessel PCI. Background The optimal treatment of patients with STEMI and multivessel disease is of continuing interest in the era of drug-eluting stents. Methods STEMI patients with multivessel disease undergoing PCIs in New York between January 1, 2003, and June 30, 2006, were subdivided into those who underwent culprit vessel PCI and those who underwent multivessel PCI during the index procedure, during the index admission, or staged within 60 days of the index admission. Patients were propensity-matched and mortality rates were calculated at 12, 24, and 42 months. Results A total of 3,521 patients (87.5%) underwent culprit vessel PCI during the index procedure. A total of 259 of them underwent staged PCI during the index admission and 538 patients underwent staged PCI within 60 days of the index procedure. For patients without hemodynamic compromise, culprit vessel PCI during the index procedure was associated with lower in-hospital mortality than multivessel PCI during the index procedure (0.9% vs. 2.4%, p = 0.04). Patients undergoing staged multivessel PCI within 60 days after the index procedure had a significantly lower 12-month mortality rate than patients undergoing culprit vessel PCI only (1.3% vs. 3.3%, p = 0.04). Conclusions Our findings support the American College of Cardiology/American Heart Association (ACC/AHA) recommendation that culprit vessel PCI be used for STEMI patients with multivessel disease at the time of the index PCI when patients are not hemodynamically compromised. However, staged PCI within 60 days after the index procedure, including during the index admission, is associated with risk-adjusted mortality rates that are comparable with the rate for culprit vessel PCI alone. (J Am Coll Cardiol Intv 2010;3:22-31) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:22 / 31
页数:10
相关论文
共 50 条
  • [31] Safety and feasibility of performing staged non-culprit vessel percutaneous coronary intervention within the index hospitalization in patients with ST-segment elevation myocardial infarction and multivessel disease
    Loh, Joshua P.
    Kitabata, Hironori
    Torguson, Rebecca
    Satler, Lowell F.
    Kent, Kenneth M.
    Suddath, William O.
    Pichard, Augusto D.
    Lindsay, Joseph
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2013, 14 (05) : 258 - 263
  • [32] Contrast-induced nephropathy after staged percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease
    马贵洲
    徐荣和
    王莹
    陈少敏
    倪楚民
    蔡志雄
    SouthChinaJournalofCardiology, 2018, 19 (03) : 143 - 156
  • [33] Culprit Vessel Versus Multivessel Intervention at the Time of Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease Real-World Analysis of 3984 Patients in London
    Iqbal, M. Bilal
    Ilsley, Charles
    Kabir, Tito
    Smith, Robert
    Lane, Rebecca
    Mason, Mark
    Clifford, Piers
    Crake, Tom
    Firoozi, Sam
    Kalra, Sundeep
    Knight, Charles
    Lim, Pitt
    Malik, Iqbal S.
    Mathur, Anthony
    Meier, Pascal
    Rakhit, Roby D.
    Redwood, Simon
    Whitbread, Mark
    Bromage, Dan
    Rathod, Krishna
    MacCarthy, Philip
    Dalby, Miles
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (06): : 936 - 943
  • [34] Meta-Analysis of Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in Patients With Non ST-Segment Elevation Acute Coronary Syndrome and Multivessel Coronary Disease
    Jang, Jae-Sik
    Jin, Han-Young
    Seo, Jeong-Sook
    Yang, Tae-Hyun
    Kim, Dae-Kyeong
    Kim, Dong-Soo
    Cho, Kyoung-Im
    Kim, Bo-Hyun
    Park, Yong Hyun
    Je, Hyung-Gon
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (08): : 1027 - 1032
  • [35] Re: Multivessel Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction with Cardiogenic Shock Response
    Rhee, Tae-Min
    Lee, Joo Myung
    Choi, Ki Hong
    Kim, Jihoon
    Kim, Hyun Kuk
    Song, Young Bin
    Hahn, Joo-Yong
    EPIDEMIOLOGY, 2018, 29 (06) : E60 - E61
  • [36] Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease
    Fukutomi, Motoki
    Toriumi, Shinichi
    Ogoyama, Yukako
    Oba, Yusuke
    Takahashi, Masao
    Funayama, Hiroshi
    Kario, Kazuomi
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (05) : E262 - E268
  • [37] Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock
    Wu, Jing
    Wang, Yonggang
    Li, Chenguang
    Ji, Honglei
    Zhao, Wenyi
    Tong, Qian
    Zhang, Mingyou
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [38] Preventive versus Culprit Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta Analysis
    Song, Yeo-Jeong
    Jang, Jae-Sik
    Kim, Byeong-Woo
    Jin, Han-Young
    Seo, Jeong-Sook
    Yang, Tae-Hyun
    Kim, Dae-Kyeong
    Kim, Dong-Soo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B4 - B4
  • [39] Complete percutaneous coronary intervention versus culprit only percutaneous coronary intervention for acute ST elevation myocardial infarction with multivessel coronary artery disease: a meta-analysis
    Almelor, L. G.
    Fomaneg, C.
    Dayag, A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 188 - 188
  • [40] Multivessel versus culprit lesion percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse?
    Radovanovic, D.
    Nallamothu, B.
    Bertel, O.
    Eberli, F.
    Pedrazzini, G.
    Windecker, S.
    Jeger, R.
    Erne, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 838 - 838